CWM, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
CWM, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25
+66.7%
1,205
+274.2%
0.00%
Q2 2023$15
+87.5%
322
+68.6%
0.00%
Q1 2023$8
+700.0%
191
+536.7%
0.00%
Q4 2022$1
-99.9%
300.0%0.00%
Q3 2022$1,0000.0%300.0%0.00%
Q2 2022$1,000
-50.0%
30
-52.4%
0.00%
Q1 2022$2,000
+100.0%
63
+350.0%
0.00%
Q4 2021$1,0000.0%140.0%0.00%
Q2 2021$1,0000.0%140.0%0.00%
Q1 2021$1,0000.0%140.0%0.00%
Q4 2020$1,0000.0%140.0%0.00%
Q3 2020$1,0000.0%140.0%0.00%
Q2 2020$1,0000.0%140.0%0.00%
Q1 2020$1,0000.0%140.0%0.00%
Q4 2019$1,0000.0%140.0%0.00%
Q3 2019$1,0000.0%140.0%0.00%
Q2 2019$1,0000.0%140.0%0.00%
Q1 2019$1,0000.0%14
+133.3%
0.00%
Q4 2018$1,0000.0%60.0%0.00%
Q3 2018$1,0000.0%60.0%0.00%
Q2 2018$1,0000.0%60.0%0.00%
Q1 2018$1,0000.0%60.0%0.00%
Q4 2017$1,00060.0%0.00%
Q3 2017$060.0%0.00%
Q2 2017$060.0%0.00%
Q1 2017$060.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 312,000$29,886,0005.11%
DAFNA Capital Management LLC 104,306$9,991,0004.97%
Palo Alto Investors LP 850,977$81,515,0004.34%
BB BIOTECH AG 1,375,229$131,733,0004.22%
Eventide Asset Management 936,000$89,659,0003.97%
TRV GP II, LLC 37,362$3,579,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 146,179$14,002,0002.11%
SUFFOLK CAPITAL MANAGEMENT LLC 111,908$10,720,0002.06%
OAK RIDGE INVESTMENTS LLC 231,483$22,174,0001.60%
Rhenman & Partners Asset Management AB 137,339$13,156,0001.50%
View complete list of SAGE THERAPEUTICS INC shareholders